Bayzed joins IPO quest as medical rivalry heats up
The cancer treatment specialist is seeking a Hong Kong listing to fund its campaign in the M&A battle for China’s private healthcare market Key Takeaways: Over the past three years, Bayzed…
Recent Articles
RELATED ARTICLES
-
Hygeia adds another top hospital to its cancer-care chain
6078.HK
- BenQ files for IPO as business looks stable, but with few growth spots
- Margins ring alarm bells as 160 Health readies IPO
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
- China fertility drive delivers growth opportunity for IVF Hospital
- Malo Medical pitches IPO to help fill China’s dentistry gap
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
Discover hidden China stock gems in our weekly newsletter